Journal of Heterocyclic Chemistry · 2018 · 20 citations · 13 references
PharmacyMedicinal ChemistryPharmacologyAntimicrobial ResistanceDrug DesignDrug DiscoveryAntibacterial PharmacologyAntibacterial ResistanceAntibiotic ResistanceMultidrug ResistanceBacterial Multidrug ResistanceCytotoxicity AssaysLipophilicity ModificationMinimum Inhibitory Concentration DeterminationMolecular LipophilicityMycobacterium Tuberculosis InfectionTuberculosis Drug DevelopmentTuberculosis Drug Resistance
A series of diethylene glycol tethered ciprofloxacin–isatin hybrids 5a–j were designed, synthesized, and evaluated for their in vitro antimycobacterial activity against both drug‐sensitive and multidrug‐resistant (MDR) Mycobacterium tuberculosis strains in this paper. The preliminary results revealed that all hybrids with greater lipophilicity than the parent ciprofloxacin displayed considerable activity against the tested strains with minimum inhibitory concentration (MIC) in a range of 1.56–64 μg/mL. In particular, hybrid 5f (MIC: 1.56 and 2 μg/mL) with low cytotoxicity in VERO cell line was comparable with the parent ciprofloxacin (MIC: 0.78 and 2 μg/mL) against M. tuberculosis H 37 Rv and MDR tuberculosis strains and ≥16‐fold more potent than isoniazid and rifampicin (MIC: >128 and 32 μg/mL, respectively) against MDR tuberculosis, suggesting that it may serve as a new and promising candidate for further study.
13
Isatin hybrids and their anti-tuberculosis activity
Zhi Xu, Shu Zhang, Chuan Gao et al. · Chinese Chemical Letters · 2016 · 258 citations
Zhi Xu, Xufeng Song, Yuan‐Qiang Hu et al. · European Journal of Medicinal Chemistry · 2017 · 116 citations